Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001066738 | SCV001231755 | uncertain significance | Bloom syndrome | 2023-03-31 | criteria provided, single submitter | clinical testing | In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Algorithms developed to predict the effect of missense changes on protein structure and function output the following: SIFT: "Not Available"; PolyPhen-2: "Benign"; Align-GVGD: "Not Available". The glycine amino acid residue is found in multiple mammalian species, which suggests that this missense change does not adversely affect protein function. ClinVar contains an entry for this variant (Variation ID: 860441). This variant has not been reported in the literature in individuals affected with BLM-related conditions. This variant is not present in population databases (gnomAD no frequency). This sequence change replaces arginine, which is basic and polar, with glycine, which is neutral and non-polar, at codon 266 of the BLM protein (p.Arg266Gly). |
Quest Diagnostics Nichols Institute San Juan Capistrano | RCV001800952 | SCV002046992 | uncertain significance | not specified | 2021-04-28 | criteria provided, single submitter | clinical testing | |
Natera, |
RCV001066738 | SCV002089971 | uncertain significance | Bloom syndrome | 2021-05-06 | no assertion criteria provided | clinical testing |